Form 4: Cardlytics Director Scott A. Hill Reports Stock Transactions
SEC Form 4 Filing
Director Scott A. Hill reports the vesting and conversion of restricted stock units into Cardlytics common stock.
Summary
- On May 23, 2025, Scott A. Hill, a director of Cardlytics, Inc., reported a transaction involving restricted stock units (RSUs).
- Hill converted 11,000 RSUs into 11,000 shares of Cardlytics common stock.
- The RSUs vested in full on the one-year anniversary of the grant date.
- Following the transaction, Hill directly owns 57,748 shares of Cardlytics common stock.
Sentiment
Score: 5
Explanation: The document is a neutral report of stock transactions by a company director. It doesn't contain any information that would significantly impact investor sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company insiders.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a routine conversion of existing equity awards.
Key Dates
| Date | Description |
|---|---|
| 05/23/2025 | Date of transaction: Conversion of Restricted Stock Units (RSUs) to Common Stock |
Keywords
Cardlytics, Director, Stock Transaction, Form 4, RSU, Scott A. Hill, CDLX, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.